CN111053238A - 一种具有解压助眠作用的功能食品及其制备方法 - Google Patents
一种具有解压助眠作用的功能食品及其制备方法 Download PDFInfo
- Publication number
- CN111053238A CN111053238A CN201911405240.9A CN201911405240A CN111053238A CN 111053238 A CN111053238 A CN 111053238A CN 201911405240 A CN201911405240 A CN 201911405240A CN 111053238 A CN111053238 A CN 111053238A
- Authority
- CN
- China
- Prior art keywords
- extract
- sleep
- functional food
- vitamin
- decompression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013376 functional food Nutrition 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 11
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 46
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 23
- 239000000419 plant extract Substances 0.000 claims abstract description 18
- 229920001353 Dextrin Polymers 0.000 claims abstract description 16
- 239000004375 Dextrin Substances 0.000 claims abstract description 16
- 235000019425 dextrin Nutrition 0.000 claims abstract description 16
- 229940069978 calcium supplement Drugs 0.000 claims abstract description 12
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000003623 enhancer Substances 0.000 claims abstract description 5
- 235000016709 nutrition Nutrition 0.000 claims abstract description 5
- 230000035764 nutrition Effects 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims description 45
- 230000000694 effects Effects 0.000 claims description 21
- 244000269722 Thea sinensis Species 0.000 claims description 11
- 230000006837 decompression Effects 0.000 claims description 11
- 239000008187 granular material Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 7
- 239000009429 Ginkgo biloba extract Substances 0.000 claims description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 6
- 229940068052 ginkgo biloba extract Drugs 0.000 claims description 6
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- 229910052709 silver Inorganic materials 0.000 claims description 6
- 239000007779 soft material Substances 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 239000011708 vitamin B3 Substances 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- 235000003283 Pachira macrocarpa Nutrition 0.000 claims description 4
- 240000001085 Trapa natans Species 0.000 claims description 4
- 235000014364 Trapa natans Nutrition 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 235000009165 saligot Nutrition 0.000 claims description 4
- 240000008866 Ziziphus nummularia Species 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 2
- 239000001116 FEMA 4028 Substances 0.000 claims description 2
- 239000002211 L-ascorbic acid Substances 0.000 claims description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 2
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- 229960004853 betadex Drugs 0.000 claims description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 2
- 229940119217 chamomile extract Drugs 0.000 claims description 2
- 235000020221 chamomile extract Nutrition 0.000 claims description 2
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 claims description 2
- 235000015872 dietary supplement Nutrition 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 235000020689 passion flower extract Nutrition 0.000 claims description 2
- 229940001884 passion flower extract Drugs 0.000 claims description 2
- 239000011770 retinyl acetate Substances 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 229940038779 valerian root extract Drugs 0.000 claims description 2
- 239000001192 valeriana officinalis l. rhizome/root Substances 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 239000011647 vitamin D3 Substances 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 7
- 230000002490 cerebral effect Effects 0.000 abstract description 6
- 210000002569 neuron Anatomy 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000005284 excitation Effects 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 abstract 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 9
- 206010022437 insomnia Diseases 0.000 description 9
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 7
- 239000001527 calcium lactate Substances 0.000 description 7
- 229960002401 calcium lactate Drugs 0.000 description 7
- 235000011086 calcium lactate Nutrition 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000000147 hypnotic effect Effects 0.000 description 4
- 208000019116 sleep disease Diseases 0.000 description 4
- 230000002618 waking effect Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 235000011201 Ginkgo Nutrition 0.000 description 3
- 244000194101 Ginkgo biloba Species 0.000 description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000020685 sleep-wake disease Diseases 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003326 hypnotic agent Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- MQWIFDHBNGIVPO-KYOSRNDESA-N valerianol Chemical compound C1C[C@@H](C(C)(C)O)C[C@@]2(C)[C@H](C)CCC=C21 MQWIFDHBNGIVPO-KYOSRNDESA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- MQWIFDHBNGIVPO-UHFFFAOYSA-N Kusunol Natural products C1CC(C(C)(C)O)CC2(C)C(C)CCC=C21 MQWIFDHBNGIVPO-UHFFFAOYSA-N 0.000 description 1
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 239000004870 Styrax Substances 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种具有解压助眠作用的功能食品及其制备方法。该具有解压助眠作用的功能食品,按重量份数计,包括:γ‑氨基丁酸5~25%、植物提取物5~30%、茶叶茶氨酚1~10%、营养加强剂0~1%、补钙剂1~5%、糊精余量。本发明提供的具有解压助眠作用的功能食品由γ‑氨基丁酸、植物提取物、补钙剂等原料制成,口感佳,食用方便,没有副作用,制备工艺简单;γ‑氨基丁酸、补钙剂和植物提取物配合,协同增效,能有效抑制神经细胞过度兴奋,改善脑血流通,调节脑神经细胞机能,促进脑代谢,可以明显增强改善睡眠。
Description
技术领域
本发明涉及食品技术领域,特别涉及一种具有解压助眠作用的功能食品及其制备方法。
背景技术
随着现代社会的生活节奏不断加快,人们无法逃避来自工作、家庭、社会等方面的精神压力,而精神压力的长时间蓄积,容易失眠。目前睡眠障碍已经成为亚健康的主要表现形式,严重降低人们的生活质量。临床上用来治疗失眠的主要选择用安眠药、安神补脑液等。安眠药通过中枢镇静,抑制大脑皮层的兴奋性程度达到催眠的效果,其治疗失眠的效果较佳,但长期使用安定片,会引起肌体耐药性和依赖性,同时对肝肾有损害作用。安神补脑液包括鹿茸、何首乌、淫羊藿、干姜、甘草等成分,益气养血,强脑安神,用于治疗肾精不足、气血两亏所致的乏力、健忘、失眠等症状。安神补脑液与安眠药相比,其副作用较小,但治疗失眠见效慢,对于严重的失眠患者的改善较小。因此人们对食用方便并可以增强免疫力和改善睡眠的保健食品存在迫切需求,但是,公开文献报道的食品很少有解压和改善睡眠的功效。
发明内容
本发明的目的在于提供一种具有解压助眠作用的功能食品及其制备方法,以解决上述技术问题。
为了实现上述目的,本发明的技术方案为:
第一方面,本发明提供的一种具有解压助眠作用的功能食品,按重量份数计,包括:γ-氨基丁酸5~25%、植物提取物5~30%、茶叶茶氨酚1~10%、营养加强剂0~1%、补钙剂1~5%、糊精余量。
优选的,所述植物提取物选自酸枣仁提取物、西番莲提取物、缬草根提取物、洋甘菊提取物、米糠提取物、圣约翰草提取物、银杏提取物、啤酒花提取物、花菱草提取物、茯苓提取物中的任意一种或多种。
进一步优选的,所述植物提取物为酸枣仁提取物。
进一步优选的,所述植物提取物包括酸枣仁提取物、圣约翰草提取物、银杏提取物、银啤酒花提取物、花菱草提取物,在所述解压助眠作用的功能食品中,所述酸枣仁提取物的用量为4~26%,所述圣约翰草提取物的用量为0.1~1%,所述银杏提取物的用量为0.1~1%,所述银啤酒花提取物的用量为0.3~1%,所述花菱草提取物的用量为0.5~1%。
优选的,所述营养加强剂选自维生素B1、维生素B2、维生素B3、维生素B12、维生素B6、醋酸维生素A、维生素D3、维生素E、L-抗坏血酸、烟酰胺、叶酸、D-泛酸钙、β-胡萝卜素中的任意一种或多种。
优选的,所述糊精选自抗性糊精、麦芽糊精、玉米糊精、β-环状糊精、α-环状糊精、γ-环状糊精中的一种或多种。
优选的,所述补钙剂选自碳酸钙、乳酸钙、乳矿物盐、磷酸三钙、磷酸钙中的一种或多种。
第二方面,本发明提供的一种如第一方面所述的具有解压助眠作用的功能食品的制备方法,包括如下步骤:
(1)将γ-氨基丁酸、补钙剂、糊精分别粉碎,过筛;
(2)按照配方量,将粉碎后的γ-氨基丁酸、补钙剂、糊精混合后,再加入茶叶茶氨酚、植物提取物、营养加强剂,混合均匀得到混料;
(3)向混料中加入水,搅拌制成软材;
(4)采用制粒机将软材制成湿颗粒;
(5)将制成的湿颗粒平铺在托盘上,再放入鼓风干燥箱中进行干燥,得到干燥颗粒;
(6)将硬脂酸镁和干燥颗粒混合后,采用压片机进行压片处理,得到具有解压助眠作用的功能食品。
优选的,所述步骤(5)中的干颗粒的水分含量不大于5%。
优选的,所述步骤(5)中的鼓风干燥的温度为50~60℃。
可以理解的是,本发明采用的γ-氨基丁酸广泛分布于动植物体内,是一种天然存在的非蛋白组成氨基酸,是一种重要的抑制性神经递质,具有多种生理活性,能促进脑的活化性,健脑益智,促进睡眠,美容润肤,延缓脑衰老机能,具有镇静、催眠、抗惊厥、降血压的生理作用。
可以理解的是,本发明采用的植物提取物由酸枣仁提取物、圣约翰草提取物、银杏提取物、银啤酒花提取物、花菱草提取物组成,其中,酸枣仁提取物中富含酸枣仁皂苷、黄酮、多糖、生物碱等有效成分,具有助眠镇静作用,同时具有一定的抗焦虑作用;银杏提取物中含有的缬草酸和缬草醇可以抗焦虑,可以抑制分解γ-氨基丁酸的酶;银啤酒花提取物富含黄酮类活性成分,能减轻忧虑,让心灵平静,对失眠很有帮助;花菱草提取物富含神经酰胺,可以抑制血清素不足造成的过度兴奋。
与现有技术相比,本发明的有益效果在于:
本发明提供的具有解压助眠作用的功能食品由γ-氨基丁酸、植物提取物、补钙剂等原料制成,口感佳,食用方便,没有副作用,制备工艺简单;植物提取物能抑制分解γ-氨基丁酸的酶,使γ-氨基丁酸持续发挥作用,同时γ-氨基丁酸、补钙剂和植物提取物配合,协同增效,能有效抑制神经细胞过度兴奋,改善脑血流通,调节脑神经细胞机能,促进脑代谢,可以明显增强改善睡眠。
具体实施方式
下面对本发明的具体实施方式作进一步说明。在此需要说明的是,对于这些实施方式的说明用于帮助理解本发明,但并不构成对本发明的限定。此外,下面所描述的本发明各个实施方式中所涉及的技术特征只要彼此之间未构成冲突就可以相互组合。
以下实施例和对比例中的风味调味剂为香草粉。
实施例1~7
按照如表1所示的配比称取各原料,然后实施下述制备方法:
(1)将γ-氨基丁酸、乳酸钙、抗性糊精分别粉碎,过筛;
(2)按照配方量,将粉碎后的γ-氨基丁酸、乳酸钙、抗性糊精混合后,再加入茶叶茶氨酚、植物提取物、维生素B1、维生素B2、维生素B3、维生素B12混合均匀得到混料;
(3)向混料中加入水,搅拌制成软材;
(4)采用制粒机将软材制成湿颗粒;
(5)将制成的湿颗粒平铺在托盘上,再放入鼓风干燥箱中在50~60℃下进行干燥,得到水分含量不大于5%的干燥颗粒;
(6)将硬脂酸镁和干燥颗粒混合后,采用压片机进行压片处理,经杀菌、包装即得每片质量约1~1.5g的具有解压助眠作用的功能食品,所述杀菌的条件为:紫外线的辐射强度90μw/cm,温度30±2℃,时间40min。
表1实施例1~7的原料配比
实施例8
为了进一步说明本发明的有益效果,本对比例先称取下述按重量百分比计的原料:γ-氨基丁酸14%、酸枣仁提取物19.9%、圣约翰草提取物0.3%、茶叶茶氨酚9%、维生素B1 0.15%、维生素B2 0.15%、维生素B3 0.15%、维生素B12 0.15%、乳酸钙3%、抗性糊精余量,然后按照实施例3的制备方法制得功能性食品。
实施例9
为了进一步说明本发明的有益效果,本对比例先称取下述按重量百分比计的原料:γ-氨基丁酸14%、酸枣仁提取物19.9%、银杏提取物0.3%、茶叶茶氨酚9%、维生素B10.15%、维生素B2 0.15%、维生素B3 0.15%、维生素B12 0.15%、乳酸钙3%、抗性糊精余量,然后按照实施例3的制备方法制得功能性食品。
对比例3
为了进一步说明本发明的有益效果,本对比例先称取下述按重量百分比计的原料:γ-氨基丁酸14%、酸枣仁提取物19.4%、银啤酒花提取物0.8%、茶叶茶氨酚9%、维生素B1 0.15%、维生素B2 0.15%、维生素B3 0.15%、维生素B12 0.15%、乳酸钙3%、抗性糊精余量,然后按照实施例3的制备方法制得功能性食品。
效果实施例
选取300例失眠患者,其中男女各半,年龄30~65岁,判断标准为以睡眠障碍的临床症状为几乎惟一的症状,睡眠障碍的临床症状包括入睡困难、睡眠不深、易醒、多梦、早醒、醒后不易再睡、醒后感不适、疲乏或白天困倦;睡眠障碍的症状每周至少发生三次,并持续一个月以上;将全部失眠患者随机平均分为9个试验组,每个试验组30人。试验方法:口服,一日两次,早晚各一次,每次服用2片功能食品,连续服用2周。
效果评定标准如下:
(1)显效:入睡速度、睡眠深度、睡眠时间均恢复正常者;
(2)有效:入睡速度和睡眠深度明显改善、睡眠时间增加大于2小时者;
(3)无效:睡眠深度、入睡速度没有改善。
试验2周后,观察并统计的效果记录如下表2所示。
表2助眠效果统计
上述效果验证的结果表明,本发明的适量的酸枣仁提取物、圣约翰草提取物、银杏提取物、银啤酒花提取物、花菱草提取物、γ-氨基丁酸和乳酸钙具有协同增效,抑制分解γ-氨基丁酸的酶,使γ-氨基丁酸持续发挥作用,同时有效抑制神经细胞过度兴奋,改善脑血流通,调节脑神经细胞机能,促进脑代谢,可以明显增强改善睡眠。
以上对本发明的实施方式作了详细说明,但本发明不限于所描述的实施方式。对于本领域的技术人员而言,在不脱离本发明原理和精神的情况下,对这些实施方式进行多种变化、修改、替换和变型,仍落入本发明的保护范围内。
Claims (9)
1.一种具有解压助眠作用的功能食品,其特征在于,按重量份数计,包括:γ-氨基丁酸5~25%、植物提取物5~30%、茶叶茶氨酚1~10%、营养加强剂0~1%、补钙剂1~5%、糊精余量。
2.根据权利要求1所述的具有解压助眠作用的功能食品,其特征在于,所述植物提取物选自酸枣仁提取物、西番莲提取物、缬草根提取物、洋甘菊提取物、米糠提取物、圣约翰草提取物、银杏提取物、啤酒花提取物、花菱草提取物、茯苓提取物中的任意一种或多种。
3.根据权利要求2所述的具有解压助眠作用的功能食品,其特征在于,所述植物提取物为酸枣仁提取物。
4.根据权利要求2所述的具有解压助眠作用的功能食品,其特征在于,所述植物提取物包括酸枣仁提取物、圣约翰草提取物、银杏提取物、银啤酒花提取物、花菱草提取物,在所述解压助眠作用的功能食品中,所述酸枣仁提取物的用量为4~26%,所述圣约翰草提取物的用量为0.1~1%,所述银杏提取物的用量为0.1~1%,所述银啤酒花提取物的用量为0.3~1%,所述花菱草提取物的用量为0.5~1%。
5.根据权利要求1所述的具有解压助眠作用的功能食品,其特征在于,所述营养加强剂选自维生素B1、维生素B2、维生素B3、维生素B12、维生素B6、醋酸维生素A、维生素D3、维生素E、L-抗坏血酸、烟酰胺、叶酸、D-泛酸钙、β-胡萝卜素中的任意一种或多种。
6.根据权利要求1所述的具有解压助眠作用的功能食品,其特征在于,所述糊精选自抗性糊精、麦芽糊精、玉米糊精、β-环状糊精、α-环状糊精、γ-环状糊精中的一种或多种。
7.一种如权利要求1~6中任一项所述的具有解压助眠作用的功能食品的制备方法,其特征在于,包括如下步骤:
(1)将γ-氨基丁酸、补钙剂、糊精分别粉碎,过筛;
(2)按照配方量,将粉碎后的γ-氨基丁酸、补钙剂、糊精混合后,再加入茶叶茶氨酚、植物提取物、营养加强剂,混合均匀得到混料;
(3)向混料中加入水,搅拌制成软材;
(4)采用制粒机将软材制成湿颗粒;
(5)将制成的湿颗粒平铺在托盘上,再放入鼓风干燥箱中进行干燥,得到干燥颗粒;
(6)将硬脂酸镁和干燥颗粒混合后,采用压片机进行压片处理,得到具有解压助眠作用的功能食品。
8.根据权利要求7中任一项所述的具有解压助眠作用的功能食品的制备方法,其特征在于,所述干颗粒的水分含量不大于5%。
9.根据权利要求7中任一项所述的具有解压助眠作用的功能食品的制备方法,其特征在于,所述鼓风干燥的温度为50~60℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911405240.9A CN111053238A (zh) | 2019-12-30 | 2019-12-30 | 一种具有解压助眠作用的功能食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911405240.9A CN111053238A (zh) | 2019-12-30 | 2019-12-30 | 一种具有解压助眠作用的功能食品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111053238A true CN111053238A (zh) | 2020-04-24 |
Family
ID=70305206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911405240.9A Pending CN111053238A (zh) | 2019-12-30 | 2019-12-30 | 一种具有解压助眠作用的功能食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111053238A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114762709A (zh) * | 2021-05-21 | 2022-07-19 | 品高生物科技(广州)有限公司 | 一种改善睡眠的植物精油及其制备方法和使用方法 |
CN115350260A (zh) * | 2022-09-05 | 2022-11-18 | 东莞市容大生物科技有限公司 | 一种用于皮肤具有助睡眠功能的日常护理生物制剂及其制备方法 |
CN115381890A (zh) * | 2022-08-01 | 2022-11-25 | 澳美制药(苏州)有限公司 | 助眠缓释片及其制备方法 |
CN116210896A (zh) * | 2022-12-12 | 2023-06-06 | 福州三合元生物科技有限公司 | 一种具有伽马氨基丁酸的保健品制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1850064A (zh) * | 2006-02-26 | 2006-10-25 | 郭凌云 | 一种减轻紧张症状的制剂 |
CN1872185A (zh) * | 2006-05-11 | 2006-12-06 | 北京东方兴企食品工业技术有限公司 | 一种具有改善睡眠作用的颗粒剂 |
US20080044499A1 (en) * | 2004-04-06 | 2008-02-21 | Taiyokagaku Co., Ltd. | Sleep Improvement Composition |
CN102038248A (zh) * | 2010-11-01 | 2011-05-04 | 华润怡宝食品饮料(深圳)有限公司 | 一种舒缓饮料 |
CN103110709A (zh) * | 2011-11-16 | 2013-05-22 | 北京康比特体育科技股份有限公司 | 一种改善睡眠的组合物及其制备方法 |
CN105077477A (zh) * | 2015-08-12 | 2015-11-25 | 北京晚安科技有限责任公司 | 一种助眠饮品 |
CN108030099A (zh) * | 2017-12-29 | 2018-05-15 | 广州硕维食品技术有限公司 | 一种有效缓解压力改善睡眠的配方营养食品及制备方法 |
CN109833381A (zh) * | 2019-04-17 | 2019-06-04 | 湖南高迪信达生物科技有限公司 | 一种改善睡眠的纯天然植物药组合物 |
-
2019
- 2019-12-30 CN CN201911405240.9A patent/CN111053238A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080044499A1 (en) * | 2004-04-06 | 2008-02-21 | Taiyokagaku Co., Ltd. | Sleep Improvement Composition |
CN1850064A (zh) * | 2006-02-26 | 2006-10-25 | 郭凌云 | 一种减轻紧张症状的制剂 |
CN1872185A (zh) * | 2006-05-11 | 2006-12-06 | 北京东方兴企食品工业技术有限公司 | 一种具有改善睡眠作用的颗粒剂 |
CN102038248A (zh) * | 2010-11-01 | 2011-05-04 | 华润怡宝食品饮料(深圳)有限公司 | 一种舒缓饮料 |
CN103110709A (zh) * | 2011-11-16 | 2013-05-22 | 北京康比特体育科技股份有限公司 | 一种改善睡眠的组合物及其制备方法 |
CN105077477A (zh) * | 2015-08-12 | 2015-11-25 | 北京晚安科技有限责任公司 | 一种助眠饮品 |
CN108030099A (zh) * | 2017-12-29 | 2018-05-15 | 广州硕维食品技术有限公司 | 一种有效缓解压力改善睡眠的配方营养食品及制备方法 |
CN109833381A (zh) * | 2019-04-17 | 2019-06-04 | 湖南高迪信达生物科技有限公司 | 一种改善睡眠的纯天然植物药组合物 |
Non-Patent Citations (3)
Title |
---|
(美)瑞秋•卡尔顿•艾布拉姆斯: "《与身体对话 终结疲惫的自疗启示录》", 31 January 2018, 北京联合出版公司 * |
蒋峰: "《终身的财富 营养健康教育指南》", 30 September 2006, 人民日报出版社 * |
郑建仙: "《功能性食品学》", 30 June 2009, 中国轻工业出版社 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114762709A (zh) * | 2021-05-21 | 2022-07-19 | 品高生物科技(广州)有限公司 | 一种改善睡眠的植物精油及其制备方法和使用方法 |
CN114762709B (zh) * | 2021-05-21 | 2023-11-24 | 品高生物科技(广州)有限公司 | 一种改善睡眠的植物精油及其制备方法和使用方法 |
CN115381890A (zh) * | 2022-08-01 | 2022-11-25 | 澳美制药(苏州)有限公司 | 助眠缓释片及其制备方法 |
CN115350260A (zh) * | 2022-09-05 | 2022-11-18 | 东莞市容大生物科技有限公司 | 一种用于皮肤具有助睡眠功能的日常护理生物制剂及其制备方法 |
CN115350260B (zh) * | 2022-09-05 | 2024-02-23 | 东莞市容大生物科技有限公司 | 一种用于皮肤具有助睡眠功能的日常护理生物制剂及其制备方法 |
CN116210896A (zh) * | 2022-12-12 | 2023-06-06 | 福州三合元生物科技有限公司 | 一种具有伽马氨基丁酸的保健品制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111053238A (zh) | 一种具有解压助眠作用的功能食品及其制备方法 | |
CN103784611B (zh) | 一种具有改善睡眠帮助缓解压力的组合物及其应用 | |
CN108030099A (zh) | 一种有效缓解压力改善睡眠的配方营养食品及制备方法 | |
US10335447B2 (en) | Solid beverage for conditioning Qi deficiency constitution and method for producing the same | |
CN104013564B (zh) | 一种油茶蜂蜜润肤品 | |
KR101551304B1 (ko) | 원지와 석창포를 이용한 건강 기능 식품용 환 및 그 제조 방법 | |
CN104694353B (zh) | 女士用保健酒及其制备方法 | |
CN103828954A (zh) | 一种减肥茶及其制作方法 | |
CN110432414A (zh) | 一种调节人体机能的霍山石斛组合饮品及其制备方法 | |
CN113841892A (zh) | 具有助眠功能的食品配方及制备方法和应用 | |
KR101789424B1 (ko) | 구기자를 포함하는 수면장애 개선용 한방조성물 및 그 제조방법 | |
CN101642176A (zh) | 一种缓解神经衰弱的酸枣蜂蜜茶的制作方法 | |
CN106798213A (zh) | 铁皮石斛保健饮料及其制作方法 | |
CN106923130A (zh) | 含西红花的固体饮料、其制备方法及应用 | |
CN103859521B (zh) | 一种海巴戟天然功能饮料及其制备方法 | |
CN105056096B (zh) | 补肾活血通络酒及其制备方法 | |
CN105558538A (zh) | 一种抗抑郁疲劳的茶氨酸组合物 | |
CN100413424C (zh) | 保健营养粉 | |
CN106923115A (zh) | 含西红花的植物饮料及其制备方法和应用 | |
CN100459984C (zh) | 一种宠物保健的组合物及其制备方法 | |
CN114403277A (zh) | 一种奶味解酒压片糖果及其制备方法 | |
CN114377109A (zh) | 一种安神助眠组合物及其制备方法和应用 | |
CN113632979A (zh) | 一种男女通用的四季养生饮料及其制备方法 | |
CN105995711A (zh) | 一种滇橄榄复方制剂及其制备方法 | |
CN105925447B (zh) | 一种含有金花葵的复方保健酒及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200424 |
|
RJ01 | Rejection of invention patent application after publication |